Cardiovascular & Metabolism Therapeutic AreaJanssen Research & Development LLCSpring House, Pennsylvania, United States
PB0558 - Lack of interaction of milvexian, an investigational oral FXIa inhibitor with aspirin and ticagrelor on platelet aggregation, thrombin generation and thromboelastography in vitro
Monday, June 26, 202318:30 – 19:30 ET
